HOME
  • About Shionogi
    • About Shionogi

        About

        • About
        • Company Profile
        • SHIONOGI Journal
        • BRAND STATEMENT
        • SHIONOGI Infectious Disease Weeks
          • Message from Top Management
          • Philosophy
          • Business Strategy
          • Business Activities
          • Shionogi's Strength
          • Group Companies
          • History
          • Policies
          • Compliance
          • Compliance Promotion Structure and Initiatives
          • Commitment to Tax Compliance
          • Ensuring High Ethical Standards and Transparency in Business Activities
          • Corporate Governance
          • Basic Views and Guidelines on Corporate Governance
          • Corporate Governance System
          • Board
          • Shareholdings
  • Sustainability
    • Sustainability

        Sustainability

        • Sustainability
        • Material Issues
          • Environment
          • Policy / Approach
          • Environmental Topics
          • Initiatives for Each Theme
          • Information Disclosure / Data
          • Society
          • Ensuring quality and safety in products and services
          • Attractive workplace
          • Respect Human Rights
          • Supply Chain Management
          • Social contribution activities
          • Governance
          • Corporate Governance
          • Risk Management
          • Compliance
          • Address the problem of antimicrobial resistance (AMR)
          • Our promise
          • Background of addressing the problem of antimicrobial resistance (AMR)
          • Long-term commitment to improving R&D to provide novel treatments for infectious diseases
          • Combating challenge of AMR
          • AMR
          • Shionogi AMR Position Paper
          • Access to healthcare
          • Developing innovative therapies to address unmet needs
          • Promote proper use of medicines
          • Improving affordability for patients in need
          • Improving access to healthcare services in developing countries
          • Stakeholder Engagement
          • Engagement with shareholders and investors
          • Engagement with customers
          • Engagement with employees
          • Engagement with society
          • Annual Report / Integrated Report / Environment Report
          • Data
          • External evaluation
          • About United Nations Global Compact
  • Innovation
    • Innovation

        Innovation

        • Innovation
        • Corporate Venture Capital
        • Pipeline
        • IP Strategy
        • Wastewater-based Epidemiology Surveillance Service
          • R&D
          • Overview of R&D
          • Drug discovery
          • Clinical Development
          • Digital therapy
          • Investigator-Initiated Research
          • Open Innovation
  • News
  • SPmenu
    • SPmenu
        • About
        • Company Profile
        • SHIONOGI Journal
        • BRAND STATEMENT
        • SHIONOGI Infectious Disease Weeks
          • Message from Top Management
          • Philosophy
          • Business Strategy
          • Business Activities
          • Shionogi's Strength
          • Group Companies
          • History
          • Policies
          • Compliance
          • SHIONOGI Group Compliance Policy
          • Compliance Promotion Structure and Initiatives
          • Commitment to Tax Compliance
          • Ensuring High Ethical Standards and Transparency in Business Activities
          • Corporate Governance
          • Basic Views and Guidelines on Corporate Governance
          • Corporate Governance System
          • Board
          • Shareholdings
        • Sustainability
        • Material Issues
          • Environment
          • Policy / Approach
          • Environmental Topics
          • Initiatives for Each Theme
          • Information Disclosure / Data
          • Society
          • Ensuring quality and safety in products and services
          • Attractive workplace
          • Respect Human Rights
          • Supply Chain Management
          • Social contribution activities
          • Governance
          • Corporate Governance
          • Risk Management
          • Compliance
          • Address the problem of antimicrobial resistance (AMR)
          • Our promise
          • Background of addressing the problem of antimicrobial resistance (AMR)
          • Long-term commitment to improving R&D to provide novel treatments for infectious diseases
          • Combating challenge of AMR
          • AMR
          • Shionogi AMR Position Paper
          • Access to healthcare
          • Developing innovative therapies to address unmet needs
          • Promote proper use of medicines
          • Improving affordability for patients in need
          • Improving access to healthcare services in developing countries
          • Stakeholder Engagement
          • Engagement with shareholders and investors
          • Engagement with customers
          • Engagement with employees
          • Engagement with society
          • Annual Report / Integrated Report / Environment Report
          • Data
          • External evaluation
          • About United Nations Global Compact
        • Innovation
        • Corporate Venture Capital
        • Pipeline
        • IP Strategy
        • Wastewater-based Epidemiology Surveillance Service
          • R&D
          • Overview of R&D
          • Drug discovery
          • Clinical Development
          • Digital therapy
          • Investigator-Initiated Research
          • Open Innovation
        News
  • Investors
  • Contact Us
  • Careers
English
Worldwide
  1. HOME
  2. Sustainability
  3. Society
  4. Respect Human Rights
  5. Initiatives for Rights Holder

Initiatives for Rights Holder

Society

Commitment to Fight COVID-19

Access to healthcare

Social contribution activities

Employee

Diversity and inclusion

Health management

Occupational Health and Safety

Supply Chain

Supply Chain Management

 

 

 

 

 

 

To all medical professionals, Patients and their families

Ensuring the Safety of Participants in Clinical Trials

 

Social Contribution Activities

 

 

  • About Shionogi
  • Sustainability
  • Innovation
  • News
  • Investors
  • ID Weeks Page
  • Terms of Service
  • Sitemap
  • Personal Information
Copyright (C) Shionogi & Co., Ltd. All Rights reserved.